North America Embolization Agents Market
The North America Embolization Agents Market size was valued at US$ 1,041.25 Mn in 2021 and is projected to reach US$ 1,763.73 Mn by 2028, growing at a CAGR of 7.8% during 2021 - 2028.
Report Coverage
- Product: Coils, Plugs, Beads/Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents
- Application: Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases
- End User: Hospitals, Cardiac Centers, Ambulatory Surgical Centers
US$ 1,041.25 Mn
Market size in 2021
US$ 1,763.73 Mn
Market Size by 2028
7.8%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Embolization Agents Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Embolization Agents Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Embolization Agents Market Regional Analysis
6.2 North America Embolization Agents Market Revenue 2019-2028 (US$ Million)
6.3 North America Embolization Agents Market Forecast Analysis
7. North America Embolization Agents Market Analysis – by Product
7.1 Coils
- 7.1.1 Overview
- 7.1.2 Coils: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Plugs
- 7.2.1 Overview
- 7.2.2 Plugs: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Beads/Particles
- 7.3.1 Overview
- 7.3.2 Beads/Particles: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Detachable Balloons
- 7.4.1 Overview
- 7.4.2 Detachable Balloons: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Glue
- 7.5.1 Overview
- 7.5.2 Glue: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.6 Sponge
- 7.6.1 Overview
- 7.6.2 Sponge: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.7 Liquid Embolics
- 7.7.1 Overview
- 7.7.2 Liquid Embolics: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.8 Sclerosants
- 7.8.1 Overview
- 7.8.2 Sclerosants: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.9 Precipitating Agents
- 7.9.1 Overview
- 7.9.2 Precipitating Agents: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Embolization Agents Market Analysis – by Application
8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Neurology
- 8.2.1 Overview
- 8.2.2 Neurology: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Urology
- 8.3.1 Overview
- 8.3.2 Urology: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Cardiology
- 8.4.1 Overview
- 8.4.2 Cardiology: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Peripheral Vascular Diseases
- 8.5.1 Overview
- 8.5.2 Peripheral Vascular Diseases: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Embolization Agents Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Cardiac Centers
- 9.2.1 Overview
- 9.2.2 Cardiac Centers: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: North America Embolization Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Embolization Agents Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Embolization Agents Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 North America Embolization Agents Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Embolization Agents Market Breakdown, by Product
- 10.2.1.1.2 US: North America Embolization Agents Market Breakdown, by Application
- 10.2.1.1.3 US: North America Embolization Agents Market Breakdown, by End User
- 10.2.1.2 Canada: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Embolization Agents Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Embolization Agents Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Embolization Agents Market Breakdown, by End User
- 10.2.1.3 Mexico : North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Embolization Agents Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Embolization Agents Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Embolization Agents Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Boston Scientific Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Cook Medical LLC
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 DePuy Synthes
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 KANEKA CORPORATION
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medtronic
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merit Medical Systems Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Penumbra, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Stryker Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Terumo Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
